https://stock.noler.com/us/stock/nkgen-biotech-inc https://stock.noler.com/us/stock/nkgen-biotech-inc/13f-holdings-corporate-securities https://stock.noler.com/us/stock/nkgen-biotech-inc/accounts-payable https://stock.noler.com/us/stock/nkgen-biotech-inc/accounts-payable-and-accrued-liabilities-current https://stock.noler.com/us/stock/nkgen-biotech-inc/accounts-receivable https://stock.noler.com/us/stock/nkgen-biotech-inc/accounts-receivable-net https://stock.noler.com/us/stock/nkgen-biotech-inc/accrued-liabilities-current https://stock.noler.com/us/stock/nkgen-biotech-inc/accumulated-depreciation https://stock.noler.com/us/stock/nkgen-biotech-inc/additional-paid-in-capital https://stock.noler.com/us/stock/nkgen-biotech-inc/allocated-share-based-compensation-expense https://stock.noler.com/us/stock/nkgen-biotech-inc/amended-reports https://stock.noler.com/us/stock/nkgen-biotech-inc/antidilutive-securities-excluded-from-computation-of-earnings-per-share-amount https://stock.noler.com/us/stock/nkgen-biotech-inc/assets-held-in-trust-noncurrent https://stock.noler.com/us/stock/nkgen-biotech-inc/auditor https://stock.noler.com/us/stock/nkgen-biotech-inc/authorized-dilution https://stock.noler.com/us/stock/nkgen-biotech-inc/basic-shares https://stock.noler.com/us/stock/nkgen-biotech-inc/beta https://stock.noler.com/us/stock/nkgen-biotech-inc/borrowing-debt https://stock.noler.com/us/stock/nkgen-biotech-inc/bridge-loan https://stock.noler.com/us/stock/nkgen-biotech-inc/business-acquisition-cost-of-acquired-entity-transaction-costs https://stock.noler.com/us/stock/nkgen-biotech-inc/buybacks-repurchase-programs https://stock.noler.com/us/stock/nkgen-biotech-inc/capital-expenditures https://stock.noler.com/us/stock/nkgen-biotech-inc/capital-expenditures-incurred-but-not-yet-paid https://stock.noler.com/us/stock/nkgen-biotech-inc/capitalized-computer-software-net https://stock.noler.com/us/stock/nkgen-biotech-inc/cash https://stock.noler.com/us/stock/nkgen-biotech-inc/cash-and-cash-equivalents-fair-value-disclosure https://stock.noler.com/us/stock/nkgen-biotech-inc/cash-and-equivalents https://stock.noler.com/us/stock/nkgen-biotech-inc/cash-and-restricted-cash https://stock.noler.com/us/stock/nkgen-biotech-inc/cash-and-securities https://stock.noler.com/us/stock/nkgen-biotech-inc/cash-equivalents-at-carrying-value https://stock.noler.com/us/stock/nkgen-biotech-inc/cash-fdic-insured-amount https://stock.noler.com/us/stock/nkgen-biotech-inc/cash-flow-breakdown https://stock.noler.com/us/stock/nkgen-biotech-inc/class-of-warrant-or-right-outstanding https://stock.noler.com/us/stock/nkgen-biotech-inc/clinical-trials https://stock.noler.com/us/stock/nkgen-biotech-inc/common-stock-capital-shares-reserved-for-future-issuance https://stock.noler.com/us/stock/nkgen-biotech-inc/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/nkgen-biotech-inc/common-stock-share-subscribed-but-unissued-subscriptions-receivable https://stock.noler.com/us/stock/nkgen-biotech-inc/common-stock-value https://stock.noler.com/us/stock/nkgen-biotech-inc/comprehensive-income https://stock.noler.com/us/stock/nkgen-biotech-inc/congressional-trades https://stock.noler.com/us/stock/nkgen-biotech-inc/convertible-debt-current https://stock.noler.com/us/stock/nkgen-biotech-inc/convertible-debt-fair-value-disclosures https://stock.noler.com/us/stock/nkgen-biotech-inc/convertible-debt-noncurrent https://stock.noler.com/us/stock/nkgen-biotech-inc/convertible-notes-payable-current https://stock.noler.com/us/stock/nkgen-biotech-inc/convertible-securities-outstanding https://stock.noler.com/us/stock/nkgen-biotech-inc/convertible-securities-retired https://stock.noler.com/us/stock/nkgen-biotech-inc/cost-of-revenue https://stock.noler.com/us/stock/nkgen-biotech-inc/costs-and-expenses https://stock.noler.com/us/stock/nkgen-biotech-inc/cover-page-shares-outstanding https://stock.noler.com/us/stock/nkgen-biotech-inc/current-assets https://stock.noler.com/us/stock/nkgen-biotech-inc/current-federal-tax-expense-benefit https://stock.noler.com/us/stock/nkgen-biotech-inc/current-liabilities https://stock.noler.com/us/stock/nkgen-biotech-inc/current-state-and-local-tax-expense-benefit https://stock.noler.com/us/stock/nkgen-biotech-inc/customer-breakdown https://stock.noler.com/us/stock/nkgen-biotech-inc/debt-and-obligation-disclosures https://stock.noler.com/us/stock/nkgen-biotech-inc/debt-conversion-converted-instrument-amount https://stock.noler.com/us/stock/nkgen-biotech-inc/debt-conversion-converted-instrument-shares-issued https://stock.noler.com/us/stock/nkgen-biotech-inc/debt-interest-rate-stated-percentage https://stock.noler.com/us/stock/nkgen-biotech-inc/deferred-costs https://stock.noler.com/us/stock/nkgen-biotech-inc/deferred-federal-income-tax-expense-benefit https://stock.noler.com/us/stock/nkgen-biotech-inc/deferred-finance-costs-current-net https://stock.noler.com/us/stock/nkgen-biotech-inc/deferred-income-tax-assets-net https://stock.noler.com/us/stock/nkgen-biotech-inc/deferred-income-tax-liabilities https://stock.noler.com/us/stock/nkgen-biotech-inc/deferred-income-tax-liabilities-net https://stock.noler.com/us/stock/nkgen-biotech-inc/deferred-income-taxes-and-tax-credits https://stock.noler.com/us/stock/nkgen-biotech-inc/deferred-state-and-local-income-tax-expense-benefit https://stock.noler.com/us/stock/nkgen-biotech-inc/deferred-tax-assets-goodwill-and-intangible-assets https://stock.noler.com/us/stock/nkgen-biotech-inc/deferred-tax-assets-gross https://stock.noler.com/us/stock/nkgen-biotech-inc/deferred-tax-assets-liabilities-net https://stock.noler.com/us/stock/nkgen-biotech-inc/deferred-tax-assets-net https://stock.noler.com/us/stock/nkgen-biotech-inc/deferred-tax-assets-operating-loss-carryforwards https://stock.noler.com/us/stock/nkgen-biotech-inc/deferred-tax-assets-stock-compensation https://stock.noler.com/us/stock/nkgen-biotech-inc/deferred-tax-assets-tax-credit-carryforwards https://stock.noler.com/us/stock/nkgen-biotech-inc/deferred-tax-assets-tax-deferred-expense-reserves-and-accruals-accrued-liabilities https://stock.noler.com/us/stock/nkgen-biotech-inc/deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/nkgen-biotech-inc/deferred-tax-liabilities https://stock.noler.com/us/stock/nkgen-biotech-inc/deferred-tax-liabilities-property-plant-and-equipment https://stock.noler.com/us/stock/nkgen-biotech-inc/depreciation https://stock.noler.com/us/stock/nkgen-biotech-inc/depreciation-and-amortization https://stock.noler.com/us/stock/nkgen-biotech-inc/derivative-gain-loss-on-derivative-net https://stock.noler.com/us/stock/nkgen-biotech-inc/derivative-liabilities-current https://stock.noler.com/us/stock/nkgen-biotech-inc/derivative-liabilities-noncurrent https://stock.noler.com/us/stock/nkgen-biotech-inc/diluted-shares https://stock.noler.com/us/stock/nkgen-biotech-inc/dilutive-securities-effect-on-basic-earnings-per-share-other https://stock.noler.com/us/stock/nkgen-biotech-inc/dividend-safety https://stock.noler.com/us/stock/nkgen-biotech-inc/due-to-related-parties-current https://stock.noler.com/us/stock/nkgen-biotech-inc/earnings-and-revenue-growth https://stock.noler.com/us/stock/nkgen-biotech-inc/earnings-per-share-basic-and-diluted https://stock.noler.com/us/stock/nkgen-biotech-inc/ebitda https://stock.noler.com/us/stock/nkgen-biotech-inc/effective-tax-rate https://stock.noler.com/us/stock/nkgen-biotech-inc/employee-related-liabilities-current https://stock.noler.com/us/stock/nkgen-biotech-inc/eps https://stock.noler.com/us/stock/nkgen-biotech-inc/eps-basic https://stock.noler.com/us/stock/nkgen-biotech-inc/executive-pay-measures https://stock.noler.com/us/stock/nkgen-biotech-inc/executive-pay-other https://stock.noler.com/us/stock/nkgen-biotech-inc/executive-pay-pvp https://stock.noler.com/us/stock/nkgen-biotech-inc/executive-pay-trading-arrangements https://stock.noler.com/us/stock/nkgen-biotech-inc/executive-salary-before-2006 https://stock.noler.com/us/stock/nkgen-biotech-inc/executive-salary-board https://stock.noler.com/us/stock/nkgen-biotech-inc/executive-salary-equity-awards https://stock.noler.com/us/stock/nkgen-biotech-inc/executive-salary-officers https://stock.noler.com/us/stock/nkgen-biotech-inc/executive-salary-other-compensation https://stock.noler.com/us/stock/nkgen-biotech-inc/executive-salary-other-mentions https://stock.noler.com/us/stock/nkgen-biotech-inc/executive-salary-pay-ratio https://stock.noler.com/us/stock/nkgen-biotech-inc/executive-salary-relatives https://stock.noler.com/us/stock/nkgen-biotech-inc/fails-to-deliver https://stock.noler.com/us/stock/nkgen-biotech-inc/fair-value-adjustment-of-warrants https://stock.noler.com/us/stock/nkgen-biotech-inc/fair-value-assets-level-1-to-level-2-transfers-amount https://stock.noler.com/us/stock/nkgen-biotech-inc/fair-value-assets-level-2-to-level-1-transfers-amount https://stock.noler.com/us/stock/nkgen-biotech-inc/fair-value-measurement-with-unobservable-inputs-reconciliations-recurring-basis-liability-value https://stock.noler.com/us/stock/nkgen-biotech-inc/financing-cash-flow https://stock.noler.com/us/stock/nkgen-biotech-inc/free-cash-flow https://stock.noler.com/us/stock/nkgen-biotech-inc/gain-loss-on-sale-of-derivatives https://stock.noler.com/us/stock/nkgen-biotech-inc/gain-loss-on-sale-of-property-plant-equipment https://stock.noler.com/us/stock/nkgen-biotech-inc/general-and-administrative-expense https://stock.noler.com/us/stock/nkgen-biotech-inc/gross-margin https://stock.noler.com/us/stock/nkgen-biotech-inc/holders-breakdown https://stock.noler.com/us/stock/nkgen-biotech-inc/impairment-of-long-lived-assets-held-for-use https://stock.noler.com/us/stock/nkgen-biotech-inc/income-loss-attributable-to-parent https://stock.noler.com/us/stock/nkgen-biotech-inc/income-loss-from-including-portion-attributable-to-noncontrolling-interest https://stock.noler.com/us/stock/nkgen-biotech-inc/income-tax https://stock.noler.com/us/stock/nkgen-biotech-inc/income-tax-at-federal-statutory-rate https://stock.noler.com/us/stock/nkgen-biotech-inc/income-taxes-paid https://stock.noler.com/us/stock/nkgen-biotech-inc/increase-decrease-in-accounts-payable https://stock.noler.com/us/stock/nkgen-biotech-inc/increase-decrease-in-accounts-payable-and-accrued-liabilities https://stock.noler.com/us/stock/nkgen-biotech-inc/increase-decrease-in-accounts-receivable https://stock.noler.com/us/stock/nkgen-biotech-inc/increase-decrease-in-accrued-income-taxes-payable https://stock.noler.com/us/stock/nkgen-biotech-inc/increase-decrease-in-accrued-liabilities https://stock.noler.com/us/stock/nkgen-biotech-inc/increase-decrease-in-due-to-related-parties https://stock.noler.com/us/stock/nkgen-biotech-inc/increase-decrease-in-operating-lease-liability https://stock.noler.com/us/stock/nkgen-biotech-inc/increase-decrease-in-other-current-liabilities https://stock.noler.com/us/stock/nkgen-biotech-inc/increase-decrease-in-other-operating-capital-net https://stock.noler.com/us/stock/nkgen-biotech-inc/increase-decrease-in-prepaid-deferred-expense-and-other-assets https://stock.noler.com/us/stock/nkgen-biotech-inc/increase-decrease-in-prepaid-expense https://stock.noler.com/us/stock/nkgen-biotech-inc/incremental-common-shares-attributable-to-call-options-and-warrants https://stock.noler.com/us/stock/nkgen-biotech-inc/incremental-common-shares-attributable-to-conversion-of-debt-securities https://stock.noler.com/us/stock/nkgen-biotech-inc/insider-holders https://stock.noler.com/us/stock/nkgen-biotech-inc/insider-transactions-corporate-securities https://stock.noler.com/us/stock/nkgen-biotech-inc/insider-transactions-other https://stock.noler.com/us/stock/nkgen-biotech-inc/insider-transactions-preferred https://stock.noler.com/us/stock/nkgen-biotech-inc/insider-transactions-stock-options https://stock.noler.com/us/stock/nkgen-biotech-inc/insider-transactions-stock-units https://stock.noler.com/us/stock/nkgen-biotech-inc/insider-transactions-swaps-forwards-futures https://stock.noler.com/us/stock/nkgen-biotech-inc/insider-transactions-warrants https://stock.noler.com/us/stock/nkgen-biotech-inc/insider-transactions-warrants/purchases https://stock.noler.com/us/stock/nkgen-biotech-inc/institutional-holders https://stock.noler.com/us/stock/nkgen-biotech-inc/interest-costs-incurred https://stock.noler.com/us/stock/nkgen-biotech-inc/interest-expense https://stock.noler.com/us/stock/nkgen-biotech-inc/interest-expense-nonoperating https://stock.noler.com/us/stock/nkgen-biotech-inc/interest-income-purchased-receivables https://stock.noler.com/us/stock/nkgen-biotech-inc/interest-paid-net https://stock.noler.com/us/stock/nkgen-biotech-inc/investing-cash-flow https://stock.noler.com/us/stock/nkgen-biotech-inc/investment-income-interest https://stock.noler.com/us/stock/nkgen-biotech-inc/investment-income-nonoperating https://stock.noler.com/us/stock/nkgen-biotech-inc/iran-activity-notices https://stock.noler.com/us/stock/nkgen-biotech-inc/late-filing-notices https://stock.noler.com/us/stock/nkgen-biotech-inc/lawsuits-defendant https://stock.noler.com/us/stock/nkgen-biotech-inc/lawsuits-plaintiff https://stock.noler.com/us/stock/nkgen-biotech-inc/lessee-operating-lease-liability-payments-remainder-of-fiscal-year https://stock.noler.com/us/stock/nkgen-biotech-inc/lessee-operating-lease-liability-undiscounted-excess-amount https://stock.noler.com/us/stock/nkgen-biotech-inc/lessor-operating-lease-payments-to-be-received https://stock.noler.com/us/stock/nkgen-biotech-inc/level-3-asset-transfers-net https://stock.noler.com/us/stock/nkgen-biotech-inc/level-3-liability-change https://stock.noler.com/us/stock/nkgen-biotech-inc/level-3-liability-gain-loss-included-in-earnings https://stock.noler.com/us/stock/nkgen-biotech-inc/level-3-liability-issues https://stock.noler.com/us/stock/nkgen-biotech-inc/liabilities-assumed https://stock.noler.com/us/stock/nkgen-biotech-inc/liabilities-fair-value-disclosure https://stock.noler.com/us/stock/nkgen-biotech-inc/lines-of-credit-current https://stock.noler.com/us/stock/nkgen-biotech-inc/litigation-reserve https://stock.noler.com/us/stock/nkgen-biotech-inc/long-term-loans-payable https://stock.noler.com/us/stock/nkgen-biotech-inc/major-holders https://stock.noler.com/us/stock/nkgen-biotech-inc/material-contracts https://stock.noler.com/us/stock/nkgen-biotech-inc/mentioned-by-other https://stock.noler.com/us/stock/nkgen-biotech-inc/mutual-fund-holders https://stock.noler.com/us/stock/nkgen-biotech-inc/net-change-in-cash https://stock.noler.com/us/stock/nkgen-biotech-inc/net-income https://stock.noler.com/us/stock/nkgen-biotech-inc/net-income-loss-available-to-common-stockholders-diluted https://stock.noler.com/us/stock/nkgen-biotech-inc/news https://stock.noler.com/us/stock/nkgen-biotech-inc/noncash-or-part-noncash-acquisition-payables-assumed https://stock.noler.com/us/stock/nkgen-biotech-inc/notes-payable-related-parties-classified-current https://stock.noler.com/us/stock/nkgen-biotech-inc/notes-payable-related-parties-current-and-noncurrent https://stock.noler.com/us/stock/nkgen-biotech-inc/number-of-reportable-segments https://stock.noler.com/us/stock/nkgen-biotech-inc/obligation-breakdown https://stock.noler.com/us/stock/nkgen-biotech-inc/operating-cash-flow https://stock.noler.com/us/stock/nkgen-biotech-inc/operating-income https://stock.noler.com/us/stock/nkgen-biotech-inc/operating-lease-assets https://stock.noler.com/us/stock/nkgen-biotech-inc/operating-lease-liability https://stock.noler.com/us/stock/nkgen-biotech-inc/operating-lease-liability-current https://stock.noler.com/us/stock/nkgen-biotech-inc/operating-lease-liability-noncurrent https://stock.noler.com/us/stock/nkgen-biotech-inc/operating-lease-payments-due https://stock.noler.com/us/stock/nkgen-biotech-inc/operating-lease-payments-due-next-twelve-months https://stock.noler.com/us/stock/nkgen-biotech-inc/operating-lease-payments-due-year-three https://stock.noler.com/us/stock/nkgen-biotech-inc/operating-lease-payments-due-year-two https://stock.noler.com/us/stock/nkgen-biotech-inc/operating-lease-right-of-use-asset-amortization-expense https://stock.noler.com/us/stock/nkgen-biotech-inc/operating-lease-weighted-average-discount-rate-percent https://stock.noler.com/us/stock/nkgen-biotech-inc/operating-loss-carryforwards https://stock.noler.com/us/stock/nkgen-biotech-inc/operating-margin https://stock.noler.com/us/stock/nkgen-biotech-inc/other https://stock.noler.com/us/stock/nkgen-biotech-inc/other-accrued-liabilities-current https://stock.noler.com/us/stock/nkgen-biotech-inc/other-current-assets https://stock.noler.com/us/stock/nkgen-biotech-inc/other-current-liabilities https://stock.noler.com/us/stock/nkgen-biotech-inc/other-income https://stock.noler.com/us/stock/nkgen-biotech-inc/other-liabilities https://stock.noler.com/us/stock/nkgen-biotech-inc/other-nonoperating-income-expense https://stock.noler.com/us/stock/nkgen-biotech-inc/other-receivables-gross-current https://stock.noler.com/us/stock/nkgen-biotech-inc/other-short-term-borrowings https://stock.noler.com/us/stock/nkgen-biotech-inc/outstanding-bonds https://stock.noler.com/us/stock/nkgen-biotech-inc/outstanding-bonds-foreign https://stock.noler.com/us/stock/nkgen-biotech-inc/outstanding-bonds-matured https://stock.noler.com/us/stock/nkgen-biotech-inc/outstanding-bonds-matured-foreign https://stock.noler.com/us/stock/nkgen-biotech-inc/outstanding-bonds-matured-unclassified https://stock.noler.com/us/stock/nkgen-biotech-inc/outstanding-bonds-unclassified https://stock.noler.com/us/stock/nkgen-biotech-inc/paid-in-capital-shares-issued-issuance-costs https://stock.noler.com/us/stock/nkgen-biotech-inc/paid-in-capital-stock-compensation https://stock.noler.com/us/stock/nkgen-biotech-inc/paid-in-kind-interest https://stock.noler.com/us/stock/nkgen-biotech-inc/patents https://stock.noler.com/us/stock/nkgen-biotech-inc/patents-active https://stock.noler.com/us/stock/nkgen-biotech-inc/patents-expired https://stock.noler.com/us/stock/nkgen-biotech-inc/patents-pending https://stock.noler.com/us/stock/nkgen-biotech-inc/patents-rejected https://stock.noler.com/us/stock/nkgen-biotech-inc/payables-and-obligations https://stock.noler.com/us/stock/nkgen-biotech-inc/payments-of-debt-issuance-costs https://stock.noler.com/us/stock/nkgen-biotech-inc/payments-of-stock-issuance-costs https://stock.noler.com/us/stock/nkgen-biotech-inc/payments-to-acquire-investments https://stock.noler.com/us/stock/nkgen-biotech-inc/payments-to-acquire-software https://stock.noler.com/us/stock/nkgen-biotech-inc/payments-to-suppliers https://stock.noler.com/us/stock/nkgen-biotech-inc/pb-ratio https://stock.noler.com/us/stock/nkgen-biotech-inc/pe-ratio https://stock.noler.com/us/stock/nkgen-biotech-inc/preferred-shares https://stock.noler.com/us/stock/nkgen-biotech-inc/preferred-shares-facts https://stock.noler.com/us/stock/nkgen-biotech-inc/preferred-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/nkgen-biotech-inc/preferred-stock-shares-authorized https://stock.noler.com/us/stock/nkgen-biotech-inc/preferred-stock-shares-issued https://stock.noler.com/us/stock/nkgen-biotech-inc/preferred-stock-shares-outstanding https://stock.noler.com/us/stock/nkgen-biotech-inc/prepaid-expense-and-other-assets-current https://stock.noler.com/us/stock/nkgen-biotech-inc/prepaid-expense-current https://stock.noler.com/us/stock/nkgen-biotech-inc/pretax-income https://stock.noler.com/us/stock/nkgen-biotech-inc/prices https://stock.noler.com/us/stock/nkgen-biotech-inc/proceeds-from-contributed-capital https://stock.noler.com/us/stock/nkgen-biotech-inc/proceeds-from-convertible-debt https://stock.noler.com/us/stock/nkgen-biotech-inc/proceeds-from-derivative-instrument-financing-activities https://stock.noler.com/us/stock/nkgen-biotech-inc/proceeds-from-issuance-initial-public-offering https://stock.noler.com/us/stock/nkgen-biotech-inc/proceeds-from-issuance-of-private-placement https://stock.noler.com/us/stock/nkgen-biotech-inc/proceeds-from-issuance-of-warrants https://stock.noler.com/us/stock/nkgen-biotech-inc/proceeds-from-lines-of-credit https://stock.noler.com/us/stock/nkgen-biotech-inc/proceeds-from-related-party-debt https://stock.noler.com/us/stock/nkgen-biotech-inc/proceeds-from-sale-of-property-plant-and-equipment https://stock.noler.com/us/stock/nkgen-biotech-inc/proceeds-from-short-term-debt https://stock.noler.com/us/stock/nkgen-biotech-inc/proceeds-from-stock-issued https://stock.noler.com/us/stock/nkgen-biotech-inc/proceeds-from-stock-options-exercised https://stock.noler.com/us/stock/nkgen-biotech-inc/proceeds-from-warrant-exercises https://stock.noler.com/us/stock/nkgen-biotech-inc/profit-loss https://stock.noler.com/us/stock/nkgen-biotech-inc/property-plant-and-equipment-gross https://stock.noler.com/us/stock/nkgen-biotech-inc/property-plant-equipment https://stock.noler.com/us/stock/nkgen-biotech-inc/ps-ratio https://stock.noler.com/us/stock/nkgen-biotech-inc/public-float https://stock.noler.com/us/stock/nkgen-biotech-inc/quick-ratio https://stock.noler.com/us/stock/nkgen-biotech-inc/receivable-from-shareholders-or-affiliates-for-issuance-of-capital-stock https://stock.noler.com/us/stock/nkgen-biotech-inc/reddit https://stock.noler.com/us/stock/nkgen-biotech-inc/related-party-transaction-expenses-from-transactions-with-related-party https://stock.noler.com/us/stock/nkgen-biotech-inc/related-party-transaction-selling-general-and-administrative-expenses-from-transactions-with-related-party https://stock.noler.com/us/stock/nkgen-biotech-inc/repayments-of-lines-of-credit https://stock.noler.com/us/stock/nkgen-biotech-inc/repayments-of-related-party-debt https://stock.noler.com/us/stock/nkgen-biotech-inc/repayments-of-short-term-debt https://stock.noler.com/us/stock/nkgen-biotech-inc/research-and-development https://stock.noler.com/us/stock/nkgen-biotech-inc/restricted-cash https://stock.noler.com/us/stock/nkgen-biotech-inc/restricted-cash-current https://stock.noler.com/us/stock/nkgen-biotech-inc/retained-earnings https://stock.noler.com/us/stock/nkgen-biotech-inc/revenue https://stock.noler.com/us/stock/nkgen-biotech-inc/right-of-use-asset-obtained-in-exchange-for-operating-lease-liability https://stock.noler.com/us/stock/nkgen-biotech-inc/sale-of-stock-consideration-received-on-transaction https://stock.noler.com/us/stock/nkgen-biotech-inc/sale-of-stock-number-of-shares-issued-in-transaction https://stock.noler.com/us/stock/nkgen-biotech-inc/sec-comment-letters https://stock.noler.com/us/stock/nkgen-biotech-inc/sec-enforcement-actions https://stock.noler.com/us/stock/nkgen-biotech-inc/sec-filings https://stock.noler.com/us/stock/nkgen-biotech-inc/sga-expense https://stock.noler.com/us/stock/nkgen-biotech-inc/share-buybacks https://stock.noler.com/us/stock/nkgen-biotech-inc/share-price https://stock.noler.com/us/stock/nkgen-biotech-inc/share-repurchases https://stock.noler.com/us/stock/nkgen-biotech-inc/shareholder-equity https://stock.noler.com/us/stock/nkgen-biotech-inc/shareholders-equity https://stock.noler.com/us/stock/nkgen-biotech-inc/shares-authorized https://stock.noler.com/us/stock/nkgen-biotech-inc/shares-issued https://stock.noler.com/us/stock/nkgen-biotech-inc/shares-issued-for-stock-awards https://stock.noler.com/us/stock/nkgen-biotech-inc/shares-outstanding-analysis https://stock.noler.com/us/stock/nkgen-biotech-inc/shares-subject-to-mandatory-redemption-settlement-terms-fair-value-of-shares https://stock.noler.com/us/stock/nkgen-biotech-inc/short-interest https://stock.noler.com/us/stock/nkgen-biotech-inc/short-sale-volume https://stock.noler.com/us/stock/nkgen-biotech-inc/short-term-borrowings https://stock.noler.com/us/stock/nkgen-biotech-inc/spending-and-interest-coverage https://stock.noler.com/us/stock/nkgen-biotech-inc/stock-award-options-exercises-in-period-average-exercise-price https://stock.noler.com/us/stock/nkgen-biotech-inc/stock-award-options-forfeitures-in-period-average-exercise-price https://stock.noler.com/us/stock/nkgen-biotech-inc/stock-award-options-grants-in-period-average-exercise-price https://stock.noler.com/us/stock/nkgen-biotech-inc/stock-based-compensation https://stock.noler.com/us/stock/nkgen-biotech-inc/stock-compensation-unrecognized-cost-stock-options https://stock.noler.com/us/stock/nkgen-biotech-inc/stock-issued-new-shares-sold https://stock.noler.com/us/stock/nkgen-biotech-inc/stock-issued-shares-issued-for-options-exercised https://stock.noler.com/us/stock/nkgen-biotech-inc/stock-issued-shares-issued-shares-conversion-of-convertible-securities https://stock.noler.com/us/stock/nkgen-biotech-inc/stock-issued-shares-issued-value-conversion-of-convertible-securities https://stock.noler.com/us/stock/nkgen-biotech-inc/stock-issued-shares-issued-value-stock-options-exercised https://stock.noler.com/us/stock/nkgen-biotech-inc/stock-options-exercisable-average-exercise-price https://stock.noler.com/us/stock/nkgen-biotech-inc/stock-options-exercisable-intrinsic-value https://stock.noler.com/us/stock/nkgen-biotech-inc/stock-options-exercisable-number https://stock.noler.com/us/stock/nkgen-biotech-inc/stock-options-exercises-in-period-total-intrinsic-value https://stock.noler.com/us/stock/nkgen-biotech-inc/stock-options-forfeitures-in-period https://stock.noler.com/us/stock/nkgen-biotech-inc/stock-options-grants-in-period-gross https://stock.noler.com/us/stock/nkgen-biotech-inc/stock-options-outstanding-average-exercise-price https://stock.noler.com/us/stock/nkgen-biotech-inc/stock-options-outstanding-intrinsic-value https://stock.noler.com/us/stock/nkgen-biotech-inc/stock-options-outstanding-number https://stock.noler.com/us/stock/nkgen-biotech-inc/stock-options-vested-and-expected-to-vest-exercisable-aggregate-intrinsic-value https://stock.noler.com/us/stock/nkgen-biotech-inc/stock-options-vested-and-expected-to-vest-exercisable-average-exercise-price https://stock.noler.com/us/stock/nkgen-biotech-inc/stock-options-vested-and-expected-to-vest-exercisable-number https://stock.noler.com/us/stock/nkgen-biotech-inc/stock-options-vested-and-expected-to-vest-outstanding-aggregate-intrinsic-value https://stock.noler.com/us/stock/nkgen-biotech-inc/stock-options-vested-and-expected-to-vest-outstanding-average-exercise-price https://stock.noler.com/us/stock/nkgen-biotech-inc/stock-options-vested-and-expected-to-vest-outstanding-number https://stock.noler.com/us/stock/nkgen-biotech-inc/stock-options-vested-in-period-fair-value https://stock.noler.com/us/stock/nkgen-biotech-inc/stock-split-ratio https://stock.noler.com/us/stock/nkgen-biotech-inc/sublease-income https://stock.noler.com/us/stock/nkgen-biotech-inc/subsidiaries https://stock.noler.com/us/stock/nkgen-biotech-inc/supplier-breakdown https://stock.noler.com/us/stock/nkgen-biotech-inc/tax-credit-carryforward-amount https://stock.noler.com/us/stock/nkgen-biotech-inc/tax-rate-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/nkgen-biotech-inc/tax-rate-reconciliation-state-and-local-income-taxes https://stock.noler.com/us/stock/nkgen-biotech-inc/tax-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/nkgen-biotech-inc/tax-reconciliation-other-adjustments https://stock.noler.com/us/stock/nkgen-biotech-inc/tax-reconciliation-state-and-local-income-taxes https://stock.noler.com/us/stock/nkgen-biotech-inc/tax-reconciliation-tax-credits-other https://stock.noler.com/us/stock/nkgen-biotech-inc/taxes-payable-current https://stock.noler.com/us/stock/nkgen-biotech-inc/taxes-payable-current-and-noncurrent https://stock.noler.com/us/stock/nkgen-biotech-inc/temporary-equity-accretion-to-redemption-value https://stock.noler.com/us/stock/nkgen-biotech-inc/temporary-equity-accretion-to-redemption-value-adjustment https://stock.noler.com/us/stock/nkgen-biotech-inc/temporary-equity-carrying-amount-attributable-to-parent https://stock.noler.com/us/stock/nkgen-biotech-inc/temporary-equity-shares-outstanding https://stock.noler.com/us/stock/nkgen-biotech-inc/total-assets https://stock.noler.com/us/stock/nkgen-biotech-inc/total-liabilities https://stock.noler.com/us/stock/nkgen-biotech-inc/total-liabilities-and-equity https://stock.noler.com/us/stock/nkgen-biotech-inc/unrealized-gain-loss-on-derivatives https://stock.noler.com/us/stock/nkgen-biotech-inc/unrecognized-tax-benefits https://stock.noler.com/us/stock/nkgen-biotech-inc/utb-decrease-from-prior-year-positions https://stock.noler.com/us/stock/nkgen-biotech-inc/utb-income-tax-penalties-and-interest-accrued https://stock.noler.com/us/stock/nkgen-biotech-inc/utb-income-tax-penalties-and-interest-expense https://stock.noler.com/us/stock/nkgen-biotech-inc/utb-increase-from-current-year-positions https://stock.noler.com/us/stock/nkgen-biotech-inc/utb-increase-from-prior-year-positions https://stock.noler.com/us/stock/nkgen-biotech-inc/valuation-allowance-deferred-tax-asset-change-in-amount https://stock.noler.com/us/stock/nkgen-biotech-inc/voting-outcome https://stock.noler.com/us/stock/nkgen-biotech-inc/weighted-average-number-of-share-outstanding-basic-and-diluted https://stock.noler.com/us/stock/nkgen-biotech-inc/youtube